General Information of HIF (ID: HIFM0090)
HIF Name
Human beta-defensin 1
HIF Synonym(s)
Hbd-1, hBD-1, BD-1, beta-defensins
HIF Classification
Antimicrobial peptide (AMP)
Molecular Function
Antibiotic; Antimicrobial; Defensin
Description hBD-1 has been identified in humans. It forms the first line of host defense against pathogenic infections and are a key component of the ancient innate immune system. [1]
Pfam Beta defensin (PF00711 )
Pathway ABC transporters (hsa02010 )
Staphylococcus aureus infection (hsa05150 )
Sequence Click here to download the HIF sequence in FASTA format
External Links
Uniprot ID
DEFB1_HUMAN
APD ID
AP00451
Microbe Species (MIC) Regulated by This HIF
         Actinomyces naeslundii (actinobacteria) MIC00033
             Description Actinomyces naeslundii is susceptibility to human beta defensin 1. [2]
         Bifidobacterium animalis subsp. lactis (actinobacteria) MIC00216
             Description Bifidobacterium animalis subsp. lactis HN019 showed increased susceptibility to 5 and 10 mg/mL of hBD-1 in the presence of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and Bifidobacterium animalis subsp. lactis HN019 were increased killed more than 20% by the concentration of hBD-1. [3]
         Bifidobacterium longum subsp. longum (actinobacteria) MIC01876
             Description Bifidobacterium longum JDM301 showed increased susceptibility to 10 mg/mL of hBD-1 in the presence of carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and Bifidobacterium longum JDM301 were increased killed 19.84% by the concentration of hBD-1. [3]
         Candida albicans (budding yeasts) MIC00317
             Description The -defensin 1 was associated with the abundance of Candida albicans. [4]
         Chlamydia trachomatis (chlamydias) MIC00344
             Description Chlamydia trachomatis induced variable increases of hBD-1 concentration. [5]
         Haemophilus influenzae (gamma-proteobacteria) MIC00652
             Description Susceptibility of nontypeable Haemophilus influenzae to human -defensins 1 is influenced by lipooligosaccharide acylation. [6]
         Helicobacter pylori (epsilon-proteobacteria) MIC00669
             Description The expression of HBD-1 exhibited enhanced antibacterial effect against Helicobacter pylori. [7]
         Lactobacillus rhamnosus (firmicutes) MIC00732
             Description Lactobacillus rhamnosus GG showed increased killing percentage by hBD-1 at any tested concentration was no more than 4%. [3]
         Streptococcus mutans (firmicutes) MIC01258
             Description Streptococcus mutans is susceptibility to human beta defensin 1. [2]
References
1 APD3: the antimicrobial peptide database as a tool for research and education.Nucleic Acids Res. 2016 Jan 4;44(D1):D1087-93. doi: 10.1093/nar/gkv1278. Epub 2015 Nov 23.
2 Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.J Clin Microbiol. 2004 Mar;42(3):1024-9. doi: 10.1128/jcm.42.3.1024-1029.2004.
3 Antimicrobial activity of human -defensins against lactic acid bacteria.Nat Prod Res. 2015;29(22):2164-6. doi: 10.1080/14786419.2014.996754. Epub 2015 Jan 6.
4 -Defensins: Farming the Microbiome for Homeostasis and Health.Front Immunol. 2019 Jan 25;9:3072. doi: 10.3389/fimmu.2018.03072. eCollection 2018.
5 [HBD-1 and hBD-2 are expressed in cervico-vaginal lavage in female genital tract due to microbial infections].Ginekol Pol. 2010 Apr;81(4):268-71.
6 Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation.Infect Immun. 2002 Sep;70(9):5287-9. doi: 10.1128/iai.70.9.5287-5289.2002.
7 A Novel View of Human Helicobacter pylori Infections: Interplay between Microbiota and Beta-Defensins.Biomolecules. 2019 Jun 18;9(6):237. doi: 10.3390/biom9060237.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.